Parallel Paths: What Retirement Plan Disruption Tells Us About the Future of Health Benefits
Retirement plan committees spent roughly fifteen years learning a set of lessons the
hard way.
For most of ERISA's history, fee transparency was a retirement plan conversation. Health and welfare committees
are now entering the same sequence —and they have the unusual advantage of being able to read ahead.
I call this Parallel Paths. The premise is simple: the forces that transformed retirement plan governance are appearing
in health benefits, in the same order, roughly a decade later.
The retirement sequence
The retirement plan transformation followed a recognizable progression.
First, transparency. Fee disclosure requirements made service provider compensation visible to plan fiduciaries
and, in aggregate, to the market. Information that had been diffuse became specific.
Then, litigation. Transparency created the factual predicate for claims. Excessive fee cases became a durable category of ERISA litigation.
Then, a shift in what mattered. Courts examining fiduciary conduct focused less on whether outcomes were good and more on whether the process that produced them was prudent. Investment performance turned out to be a weak
defense. Documented, objective decision making turned out to be a strong one.
Then, independent evaluation became normal. Committees that had relied on incumbent providers to frame their own reviews began engaging third parties to run competitive searches with criteria set in advance.
Finally, consolidation. Fee compression and margin pressure drove recordkeeper mergers, exits, and acquisitions — which in turn forced additional sponsor evaluations.
Where health benefits sit on that path Transparency has arrived and is expanding.
The 2021 Consolidated Appropriations Act extended ERISA's service provider fee disclosure framework to group health plans, requiring brokers and consultants expecting $1,000 or more in direct or indirect compensation to disclose it to the plan fiduciary. Subsequent amendments have widened that obligation well beyond brokers and consultants into the broader vendor chain. Pharmacy benefit manager contracting has drawn its own reform attention.
Litigation is underway.
Health and welfare fiduciary claims have grown meaningfully. Complaints have alleged that plan sponsors permitted excessive broker and consultant compensation, failed to benchmark premiums or monitor loss ratios, did not meaningfully evaluate carrier selection, and allowed dual compensation arrangements to operate without scrutiny. PBM arrangements feature prominently, given their share of plan spend.
Process scrutiny is beginning.
The questions being asked of health plan fiduciaries increasingly resemble the questions asked of retirement committees
a decade ago: how did you select this vendor, what did you compare, what did
you pay, and where is it written down.
Independent evaluation is not yet standard.
This is the clearest gap. In retirement, third-party-run searches with predefined criteria became common practice. In health benefits, most vendor reviews are still conducted by the incumbent broker as part of the renewal cycle.
Consolidation is accelerating.
Private equity investment in the benefits brokerage and administration sector has produced rapid consolidation, which changes service models, compensation structures, and vendor relationships in ways plan sponsors did not select.
The structural issue at the center
In most health benefit programs, the broker occupies a position that has no clean retirement analogue.
The broker advises on plan design, is frequently compensated in part by carriers rather than the plan, recommends downstream vendors such as TPAs, PBMs, stop-loss carriers, and point solutions — and may receive compensation connected to those recommendations. The same party then typically conducts the annual review of the arrangement it built.
This is not an accusation. Most brokers operate with integrity and deliver substantial value, and these compensation structures are longstanding industry practice rather than anything hidden.
But it is a structure, and structures get examined. The retirement industry worked through an equivalent question — whether an advisor could credibly evaluate services it had a financial interest in — and arrived at a fairly settled answer: it depends on whether the evaluator's compensation
changes based on the result, and it must be disclosed, evaluated, and documented either way.
Health benefits have not yet had that conversation at scale.
What the head start is worth
The practical value of the Parallel Paths framework is not prediction. It is that health plan fiduciaries can adopt proven practices before they are compelled to.
Four things retirement committees learned, largely under pressure, that translate directly:
Know total compensation, not visible compensation. Direct fees are the smaller part of the picture. Overrides, bonuses, allowances, and referral compensation are where the substance sits — and
reasonableness cannot be assessed against an incomplete number.
Set criteria before you see proposals. Criteria established in advance
demonstrate an objective process. Criteria assembled afterward demonstrate a justification. The distinction is visible in the dates.
Document reasoning, not just decisions. "The committee reviewed and approved" records attendance. "The committee selected Vendor B despite higher cost based on network adequacy and data reporting capability" records prudence.
Treat oversight as continuous. Vendor selection is a moment. Monitoring is a duty. A file that ends at the contract date describes a committee that stopped.
What this does not require
Adopting a more rigorous process does not mean replacing your broker, distrusting your advisors, or going to market annually. Many committees that run a genuine competitive evaluation retain their incumbent — and that outcome is the most valuable one available, because the relationship is now market-tested and documented rather than merely familiar. The goal is not different vendors. It is a defensible basis for whichever vendors you have.
Retirement plan fiduciaries learned that process is what gets evaluated, and most of them learned it during a period ofexpensive litigation and regulatory pressure rather than in advance. Health and welfare fiduciaries are in theearlier part of that same sequence, with an advantage retirement committees never had: a fully documented map of what comes next.
The practices that turned out to matter are not exotic
Complete compensation information.Criteria set in advance.
Objective comparison.
Written reasoning.
Continuing oversight.
Those are available to any benefits committee today, at the cost of some deliberate attention. They will be considerably more expensive to assemble retroactively.
Learn more about health plan fee disclosure here and see some of our Health Benefit Broker evaluations services HERE.
If your benefits committee and your retirement committee have never compared notes on process, that
conversation is worth an hour.
